NanoGhost Overview
- Year Founded
-
2019

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Crowdfunding
- Investors
-
3
NanoGhost General Information
Description
Developer of a drug-delivery technology designed to shrink the deadliest forms of cancer by precisely targeting tumors. The company's technology uses adult stem cells to transport medicine directly to the tumor site which aids in reducing tumor size in small lung carcinoma, prostate, and pancreatic cancer tumors, enabling patients suffering from cancer to reduce the pain of radiology treatments.
Contact Information
Website
www.nano-ghost.comCorporate Office
- 12 Beni Gaon Street
- P.O.B. 8936
- Netanya
- Israel
Corporate Office
- 12 Beni Gaon Street
- P.O.B. 8936
- Netanya
- Israel
NanoGhost Timeline
NanoGhost Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Equity Crowdfunding | 04-Mar-2024 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 01-Jun-2023 | Completed | Pre-Clinical Trials | |||
1. Seed Round | 23-Dec-2019 | $5M | $5M | Completed | Pre-Clinical Trials |
NanoGhost Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Preferred A | ||||||||
Preferred A1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NanoGhost Patents
NanoGhost Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3222298-A1 | Compositions comprising spherical particles and uses of same | Pending | 13-Jun-2021 | ||
EP-4355309-A1 | Compositions comprising spherical particles and uses of same | Pending | 13-Jun-2021 | ||
US-20240279591-A1 | Compositions comprising spherical particles and uses of same | Pending | 13-Jun-2021 | C12M47/06 |
NanoGhost Signals
NanoGhost Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Altshuler Shaham Investment House | Corporation | Minority | ||
aMoon Fund | Venture Capital | Minority | ||
NewGate Capital | Venture Capital | Minority |
NanoGhost FAQs
-
When was NanoGhost founded?
NanoGhost was founded in 2019.
-
Where is NanoGhost headquartered?
NanoGhost is headquartered in Netanya, Israel.
-
What is the size of NanoGhost?
NanoGhost has 12 total employees.
-
What industry is NanoGhost in?
NanoGhost’s primary industry is Drug Delivery.
-
Is NanoGhost a private or public company?
NanoGhost is a Private company.
-
What is NanoGhost’s current revenue?
The current revenue for NanoGhost is
. -
How much funding has NanoGhost raised over time?
NanoGhost has raised $6.87M.
-
Who are NanoGhost’s investors?
Altshuler Shaham Investment House, aMoon Fund, and NewGate Capital have invested in NanoGhost.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »